BioPharma Credit Investments V (Cayman) LP

CIK 1780110 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for BioPharma Credit Investments V (Cayman) LP.

Recent SEC filings

FiledFormAccession number
May 28, 2026D/A0001315863-26-000445
May 28, 2025D/A0001315863-25-000417
May 30, 2024D/A0001315863-24-000490
Jun 2, 2023D/A0001315863-23-000570
Jun 2, 2022D/A0001315863-22-000450
May 28, 2021D/A0001315863-21-000485
May 29, 2020D/A0001315863-20-000508
Jun 20, 2019D0001315863-19-000522